Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page adds sections for No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and adjusts the Intervention/Treatment heading; it also removes the old Intervention / Treatment heading and old Revision label while adding Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.5, was added, replacing the previous v3.5.4. This reflects a minor platform update without changing study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-05T09:58:22.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a new revision label, Revision: v3.5.4, replacing the previous v3.5.3, indicating an internal update to the page version without changing publicly visible study information.
    Difference
    0.0%
    Check dated 2026-05-14T23:13:08.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added, replacing the previous v3.5.2. This reflects a small internal update to the page template rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-30T17:15:42.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T09:35:30.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:22:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.